BioMedPartners, a leading life science VC in central Europe
What are we looking for?
We invest in innovative private early- to mid-stage human Life Science companies that address urgent medical needs with novel technologies or products with decisive advantages over current treatment options and that are backed by compelling science.
Where do we invest?
Our focus is on Switzerland and surrounding EU countries Germany, Austria, France, Italy and Benelux. We mostly invest in drug development and, to a lesser degree, in diagnostics and medical technology.
How do we invest?
The amount we aim to invest over the life time of our portfolio companies is about CHF 2 - 10 million. BioMedPartners often plays the lead or co-lead investor role structuring the transaction and syndicating with other venture capital firms.